Incidence and Survival of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in the Contemporary Era - Scorecard - MDSpire

Incidence and Survival of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in the Contemporary Era

  • By

  • Julie Hallet

  • Léamarie Meloche-Dumas

  • Carlotta Sarzo

  • Colin Court

  • Jessica Armah

  • Anna Ding

  • Wing C. Chan

  • Simron Singh

  • June 3, 2026

  • 0 min

Share

Clinical Scorecard: Trends in the Incidence and Prognosis of Gastro-Entero-Pancreatic Neuroendocrine Tumors in Modern Times

At a Glance

CategoryDetail
Condition
Key MechanismsCharacterized by slower growth and heterogeneity in presentation and behavior.
Target Population
Care Setting

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

      Management

        Monitoring & Follow-up

          Risks

            Patient & Prescribing Data

            Clinical Best Practices

              Related Resources & Content

              Original Source(s)

              Incidence and Survival of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in the Contemporary Era

              • by Julie Hallet, Léamarie Meloche-Dumas, Carlotta Sarzo, Colin Court, Jessica Armah, Anna Ding, Wing C. Chan, Simron Singh

              • June 3, 2026

              Related Content

              Leveraging deep learning and explainable AI for effective liver tumor classification from CT scan images

              Case Report: Response to ivosidenib in patients with cholangiocarcinoma: a clinical perspective with illustrative cases

              HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines Committee